Search

everythinglearnresearchcommunity

for

Search:↓

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Some skin problems can be signs of diabetes or other metabolic diseases and recognizing them can help diagnose and treat these diseases early.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Early diagnosis and tailored treatments are crucial for managing ichthyosis syndromes with hair abnormalities.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Bariatric surgery affects skin health, causing both direct complications and changes in existing skin conditions, often related to nutritional deficiencies.

Mesenchymal stem cells could help treat aging-related diseases better than current methods.

Alopecia areata involves immune response and gene changes affecting hair loss.

MSUD patients need careful monitoring of amino acids and zinc to prevent severe symptoms.

Over half of the children had abnormal hair under a microscope, with many having genetic hair conditions.

The document reports a unique case of woolly hair with a combination of conditions not previously seen together.

The patient was diagnosed with oral lichen sclerosus and needs long-term monitoring.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Zinc is effective for treating various skin conditions, including warts and acne.

The document concludes that unruly hair can be congenital or acquired, often lacks specific treatments, and can be managed with oils and short hairstyles.

Hair problems can be caused by genetics or the environment, and treatment should focus on the cause and reducing hair damage.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

A woman with acne and baldness was found to have a rare ovarian condition but successfully had a child through fertility treatment.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

Hair microscopy is a simple and cost-effective method to help diagnose systemic diseases in children.

Diabetes often causes various skin problems and complications.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.